DigestRedComo funciona
Red
/
Empresas
Je
No verificado

Jeito Capital

Sobre qué escribimos

Anuncios brevesBiotecnologíaFarmacéuticaFinanzasPublicidad/Marketing/Medios de comunicación/Comunicación

14 Comunicados de prensa

Ver todos los comunicados de prensa
05/05/2026
Mercado laboral
Industria
Ciencia
Recursos Humanos
Finanzas
Asociaciones/Profesionales
Biotecnología
Salud
Farmacéutica
Jeito Capital Bolsters Its Leadership Team With the Appointment of Elaine Caughey, MBA, as Partner, Business Development and Investor Relations, and Sarah Shackelton, MPA, as Partner, Talent
Fuente
Jeito Capital
Editor
Business Wire
1.00
0
14/04/2026
Biotecnología
Farmacéutica
Salud
Oncología
Jeito Capital leads oversubscribed $75 million Series C in Adcendo ApS to Advance its First- and Best-in-class Clinical ADC1 Pipeline in Oncology
Fuente
Jeito Capital
Editor
Business Wire
1.00
0
08/04/2026
Cardiología
Biotecnología
Farmacéutica
Oncología
Salud
Administración de Empresas
Asociaciones/Profesionales
Jeito Capital Hits Record $1.2 Billion (€1 Billion)1 Close for Jeito II Fund to Drive Breakthrough Therapeutic Innovation for Patients
Fuente
Jeito Capital
Editor
Business Wire
1.00
0
24/02/2026
Finanzas
Anuncios breves
Publicidad/Marketing/Medios de comunicación/Comunicación
Jeito Capital Makes Significant Investment in the Second Closing of Alveus Therapeutics’ Oversubscribed Series A, Bringing Total Financing to $197 Million
Fuente
Jeito Capital
Editor
GLOBENEWSWIRE
1.00
0
15/10/2025
Finanzas
Publicidad/Marketing/Medios de comunicación/Comunicación
Anuncios breves
Jeito Capital promotes Ksenija Pavletic to General Partner
Fuente
Jeito Capital
Editor
GLOBENEWSWIRE
1.00
0
10/09/2025
Finanzas
Anuncios breves
Jeito Capital announces significant participation in oversubscribed $213M Series D financing for Odyssey Therapeutics to advance clinical pipeline addressing autoimmune diseases with high unmet needs
Fuente
Jeito Capital
Editor
GLOBENEWSWIRE
1.00
0
20/05/2025
Finanzas
Publicidad/Marketing/Medios de comunicación/Comunicación
Anuncios breves
Jeito Capital Leads a USD 65 million Financing in ReproNovo to Develop Transformational Treatments in Reproductive Medicine and Women’s Health
Fuente
Jeito Capital
Editor
GLOBENEWSWIRE
1.00
0
12/05/2025
Finanzas
Publicidad/Marketing/Medios de comunicación/Comunicación
Anuncios breves
Jeito Capital leads EUR 132 million oversubscribed Series B financing in Azafaros to advance Phase 3 clinical programs of innovative therapies in rare inherited neuro-metabolic disorders
Fuente
Jeito Capital
Editor
GLOBENEWSWIRE
1.00
0
11/05/2025
Finanzas
Anuncios breves
Jeito Capital Strengthens Leadership for Next Chapter of Growth: Mehdi Ainouche Promoted to Partner, Julien Elric to Senior Principal
Fuente
Jeito Capital
Editor
GLOBENEWSWIRE
1.00
0
23/03/2025
Finanzas
Publicidad/Marketing/Medios de comunicación/Comunicación
Anuncios breves
Jeito Capital co-leads the oversubscribed €78 million financing in Augustine Therapeutics to develop novel therapies for neuromuscular, cardio-metabolic and neurodegenerative diseases
Fuente
Jeito Capital
Editor
GLOBENEWSWIRE
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0